These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6032054)

  • 1. Drug urinary excretion data--some aspects concerning the interpretation.
    Martin BK
    Br J Pharmacol Chemother; 1967 Feb; 29(2):181-93. PubMed ID: 6032054
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of data from drug urinary excretion.
    Martin BK
    Nature; 1967 Apr; 214(5085):247-9. PubMed ID: 6034239
    [No Abstract]   [Full Text] [Related]  

  • 3. Method for estimating rate constants for absorption, metabolism, and elimination from urinary excretion data.
    Wagner JG
    J Pharm Sci; 1967 Apr; 56(4):489-94. PubMed ID: 6034546
    [No Abstract]   [Full Text] [Related]  

  • 4. Fallacy in concluding there are zero-order kinetics from blood level and urinary excretion data.
    Wagner JG
    J Pharm Sci; 1967 May; 56(5):586-94. PubMed ID: 6032770
    [No Abstract]   [Full Text] [Related]  

  • 5. Equations for excretion rate and renal clearances of exogenous substances not actively reabsorbed.
    Wagner JG
    J Clin Pharmacol J New Drugs; 1967; 7(2):89-92. PubMed ID: 5230427
    [No Abstract]   [Full Text] [Related]  

  • 6. [Graphic method of assessing the maximum cumulative excretion of a drug].
    Firsov AA
    Antibiotiki; 1983 Dec; 28(12):904-8. PubMed ID: 6660844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of urinary pH on renal excretion of drugs.
    Madan PL
    JAMA; 1977 Jul; 238(3):210. PubMed ID: 17758
    [No Abstract]   [Full Text] [Related]  

  • 8. Lag time before essentially constant urinary excretion rate is attained.
    Wagner JG; Northam JI
    J Pharm Sci; 1968 Jun; 57(6):994-9. PubMed ID: 5671348
    [No Abstract]   [Full Text] [Related]  

  • 9. Application of urinary excretion studies to dosage form evaluation.
    Baldridge JL
    Bull Parenter Drug Assoc; 1969; 23(1):40-7. PubMed ID: 5765720
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of time errors on infinity values obtained using Prony's method.
    Newburger J; Stavchansky S; Pearlman RS
    J Pharm Sci; 1980 Oct; 69(10):1231-2. PubMed ID: 7420300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics and compartmental analysis].
    Grégoire F
    J Pharm Belg; 1972; 26(3):355-70. PubMed ID: 5048358
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonlinear dose-concentration relationships.
    Krüger-Thiemer E
    Farmaco Sci; 1968 Aug; 23(8):717-56. PubMed ID: 5670114
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug distribution and effect.
    Curry SH
    J R Coll Physicians Lond; 1970 Jul; 4(4):315-34. PubMed ID: 4948351
    [No Abstract]   [Full Text] [Related]  

  • 14. [Methodical problems in clinical-pharmacological research].
    Dengler HJ
    Arzneimittelforschung; 1971 Oct; 21(10):1484-7. PubMed ID: 5171864
    [No Abstract]   [Full Text] [Related]  

  • 15. Classical bioavailability methods: blood levels and urinary excretion.
    Dittert LW
    Psychopharmacol Bull; 1976 Oct; 12(4):54-5. PubMed ID: 972991
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal excretion.
    Bekersky I
    J Clin Pharmacol; 1987 Jul; 27(7):447-9. PubMed ID: 3308974
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of streptozotocin-induced diabetes on drug metabolism in rats.
    Emudianughe TS; Kalderon B; Gopher A; Lapidot A
    Arch Int Pharmacodyn Ther; 1988; 293():14-9. PubMed ID: 3421773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion of drugs in chronic renal impairment with respect to changes their tubular handling by residual nephrons.
    Schück O; Grafnetterová J; Nádvorniková H; Prát V
    Int J Clin Pharmacol Biopharm; 1976 Sep; 14(2):149-54. PubMed ID: 1036732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical considerations of the random selection process in a drug-test program.
    Burtis CA; Owings JH; Leete RS
    Clin Chem; 1987 Oct; 33(11 Suppl):46B-48B. PubMed ID: 3677409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological backgrounds of drug interaction.
    Offerhaus L
    Neth J Med; 1973; 16(4):230-6. PubMed ID: 4147969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.